The management of patients with osteoarthritis by a primary care physician: focus on efficacy and safety
https://doi.org/10.21518/2079-701X-2018-9-50-54
Abstract
The management of patients with osteoarthritis and comorbidity in the general medical practice is an urgent task. The article presents the recommendations of recent years on this problem, both international and national ones. The basic therapy for comorbid patients with osteoarthritis includes slow-acting anti-arthrosis drugs, mainly chondroitin sulfate and glucosamine, as well as their combination. The efficacy and safety of the combination has been proved by studies in recent years. The article presents an algorithm for managing comorbid patients with osteoarthritis by a primary care physician, taking into account concomitant diseases.
References
1. McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage, 2014, 22: 363–388.
2. Bruyère O, Cooper C, Pelletier J-P, Branko J, Brandy ML et al. An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: A report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Seminars in Arthritis and Rheumatism, 2014: 2–11.
3. Bruyere O, Cooper C, Pelletier J-P et al. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis – From evidence-based medicine to the real-life setting. Semin Arthritis Rheum, 2016 Feb, 45(4 Suppl): S3-S11.
4. Management of patients with osteoarthritis and comorbidity in the general medical practice. Clinical guidelines. Moscow, 2016
5. Hochberg MC, Martel-Pelletier J, Monfort J et al. Randomized, double-blind, multicenter, non inferiority clinical trial with combined glucosamine and chondroitin sulfate vs celecoxib for painful knee osteoarthritis. Osteoarthritis and cartilage, 2014, 20: S7-S56.
6. Fransen М. Glucosamine and chondroitin for knee osteoarthritis: a double-blind randomised placebo-controlled clinical trial evaluating single and combination regimens. Ann Rheum Dis, 2013, 20: 3954. Published Online First 6 January 2014.
7. Svetlova MS. Knee osteoarthritis: diagnosis and structural-modifying therapy with teraflex. RMJ, 2011, 19 (19): 1959-1964.
8. Svetlova MS. Use of Teraflex for the treatment of patients with knee osteoarthritis. Consilium Medicum. Revmatologiya, 2010, 2 (12): 136-140.
9. Lambert C. Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate. Arthritis Research & Therapy, 2012, 14: R58.
10. Salta JA. Cancer Epidemiol. Biomarkers Prev, 2009, 18: 1419-1428. 11. Navarro SL. PloS One, 2015, 26: 45-49. 12. Bell GA. Eur Epidemiol, 2012, 27: 593-603.
Review
For citations:
Svetlova MS. The management of patients with osteoarthritis by a primary care physician: focus on efficacy and safety. Meditsinskiy sovet = Medical Council. 2018;(9):50-54. (In Russ.) https://doi.org/10.21518/2079-701X-2018-9-50-54
Views:
742
Email this article 